Effective Targeting of Liposomes to Liver and Hepatocytes In Vivo by Incorporation of a Plasmodium Amino Acid Sequence

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Pharmaceutical Research

• Publication date

  2006-03-24

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s11095-006-9609-xPMID 16550476
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Design of a pH-sensitive pore-forming peptide with improved performance.

  2008cited by this paper
• An apolipoprotein E-derived peptide mediates uptake of sterically stabilized liposomes into brain capillary endothelial cells.

  2005cited by this paper
• Development of cell-specific targeting systems for drugs and genes.

  2005cited by this paper
• A Binding Site for Highly Sulfated Heparan Sulfate Is Identified in the N Terminus of the Circumsporozoite Protein

  2004cited by this paper
• Simple synthesis of diastereomerically pure phosphatidylglycerols by phospholipase D-catalyzed transphosphatidylation

  2004cited by this paper
• Biodistribution and uptake of liposomes in vivo.

  2004cited by this paper
• Heparan sulfate proteoglycan as a plasma membrane carrier.

  2003cited by this paper
• Targeted and sustained drug delivery using PEGylated galactosylated liposomes.

  2003cited by this paper
• Esterification: Methods, Reactions, and Applications

  2003cited by this paper
• Targeting Efficiency of Galactosylated Liposomes to Hepatocytes in Vivo: Effect of Lipid Composition

  2002cited by this paper
• Function of Region I and II Adhesive Motifs ofPlasmodium falciparum Circumsporozoite Protein in Sporozoite Motility and Infectivity*

  2002cited by this paper
• Proteoglycans mediate malaria sporozoite targeting to the liver

  2002cited by this paper
• Targeting liposomes and lipoplexes to cells in the liver.

  2002cited by this paper
• Invasion of mammalian host cells by Plasmodium sporozoites

  2002cited by this paper
• Targeting hepatocytes for drug and gene delivery: emerging novel approaches and applications.

  2002cited by this paper
• Order out of chaos: assembly of ligand binding sites in heparan sulfate.

  2002cited by this paper
• Not All Perlecans Are Created Equal

  2002cited by this paper
• Cell Type-specific Differences in Glycosaminoglycans Modulate the Biological Activity of a Heparin-binding Peptide (RKRLQVQLSIRT) from the G Domain of the Laminin α1 Chain*

  2001cited by this paper
• Compaction of DNA in an anionic micelle environment followed by assembly into phosphatidylcholine liposomes.

  2000cited by this paper
• The journey of the malaria sporozoite through its hosts: two parasite proteins lead the way.

  2000cited by this paper
• Functions of cell surface heparan sulfate proteoglycans.

  1999influential reference
• Regulated Diversity of Heparan Sulfate*

  1998cited by this paper
• Trifluoroacetic acid cleavage and deprotection of resin-bound peptides following synthesis by Fmoc chemistry.

  1997cited by this paper
• Microbial adherence to and invasion through proteoglycans

  1997cited by this paper
• Different intrahepatic distribution of phosphatidylglycerol and phosphatidylserine liposomes in the rat

  1997cited by this paper
• Comparison of circumsporozoite proteins from avian and mammalian malarias: biological and phylogenetic implications.

  1996cited by this paper
• Malarial Circumsporozoite Protein Is a Novel Gene Delivery Vehicle to Primary Hepatocyte Cultures and Cultured Cells (*)

  1995cited by this paper
• Liver heparan sulfate structure. A novel molecular design.

  1994cited by this paper
• Malaria sporozoite-hepatocyte interactions.

  1994cited by this paper
• Cell surface syndecan-1 on distinct cell types differs in fine structure and ligand binding of its heparan sulfate chains.

  1994cited by this paper
• Malaria circumsporozoite protein binds to heparan sulfate proteoglycans associated with the surface membrane of hepatocytes

  1993cited by this paper
• α‐Cyano‐4‐hydroxycinnamic acid as a matrix for matrixassisted laser desorption mass spectromtry

  1992cited by this paper
• HBTU activation for automated Fmoc solid-phase peptide synthesis.

  1991cited by this paper
• Application of HBTU activation for automated Fmoc solid phase peptide synthesis

  1991cited by this paper
• The liver sieve: Considerations concerning the structure and function of endothelial fenestrae, the sinusoidal wall and the space of disse

  1985cited by this paper
• Principles of fluorescence spectroscopy

  1983cited by this paper
• Direct infection of hepatocytes by sporozoites of Plasmodium berghei.

  1982cited by this paper
• Distribution of organelles and membranes between hepatocytes and nonhepatocytes in the rat liver parenchyma. A stereological study

  1977cited by this paper
• Prepatent periods of a tropical strain of Plasmodium vivax after inoculations of tenfold dilutions of sporozoites.

  1976cited by this paper
• Observations on the fine structure and peroxidase cytochemistry of normal rat liver Kupffer cells.

  1974cited by this paper
• An ultrastructural characterization of the endothelial cell in the rat liver sinusoid under normal and various experimental conditions, as a contribution to the distinction between endothelial and Kupffer cells.

  1972cited by this paper
• An electron microscopic study of the fenestrated endothelial lining of rat liver sinusoids.

  1970cited by this paper
• A rapid method of total lipid extraction and purification.

  1959influential reference

• Emerging nanotechnology-driven drug delivery solutions for malaria: Addressing drug resistance and improving therapeutic success.

  2025cites this paper
• Advancing liposome technology for innovative strategies against malaria.

  2024cites this paper
• A Comparison of Cellular Uptake Mechanisms, Delivery Efficacy, and Intracellular Fate between Liposomes and Extracellular Vesicles

  2023cites this paper
• Modular Nanotheranostic Agents for Protistan Parasitic Diseases: Magic bullets with tracers.

  2023cites this paper
• Circumsporozoite Protein of Plasmodium berghei- and George Baker Virus A-Derived Peptides Trigger Efficient Cell Internalization of Bioconjugates and Functionalized Poly(ethylene glycol)-b-poly(benzyl malate)-Based Nanoparticles in Human Hepatoma Cells

  2022cites this paper
• A Comprehensive Review on Liver Targeting: Emphasis on Nanotechnology-Based Molecular Targets and Receptors Mediated Approaches.

  2022cites this paper
• Polymeric Nanoparticle Based Diagnosis and Nanomedicine for Treatment and Development of Vaccines for Cerebral Malaria: A Review on Recent Advancement.

  2021cites this paper
• Liposomes for malaria management: the evolution from 1980 to 2020

  2021cites this paper
• Nanotechnology and Its Role in Malaria Treatment

  2020cites this paper
• Promising nanomaterials in the fight against malaria.

  2020cites this paper
• A Review of Nanotechnology for Targeted Anti-schistosomal Therapy

  2020cites this paper
• Green Nanoparticles: Synthesis and Biomedical Applications

  2020cites this paper
• Nano Drugs for Curing Malaria

  2019cites this paper
• Nano-biotechnology: a new approach to treat and prevent malaria

  2019cites this paper
• Design and Optimization of PLGA Particles to Deliver Immunomodulatory Drugs for the Prevention of Skin Allograft Rejection

  2019cites this paper
• Nano-facilitated drug delivery strategies in the treatment of plasmodium infection.

  2019cites this paper
• Application of Liposomes Nanoparticles in the Treatment of Malaria: A Mini Review

  2018cites this paper
• Malaria treatment using novel nano-based drug delivery systems

  2017cites this paper
• Antitumor activities of Liver-targeting peptide modified Recombinant human Endostatin in BALB/c-nu mice with Hepatocellular carcinoma

  2017cites this paper
• Recent advances in use of silver nanoparticles as antimalarial agents.

  2017cites this paper
• Ultrastructural and Morphometrical Study of Gestational Induced Changes in Mouse Liver

  2017cites this paper
• IMMUNOHISTOCHEMICAL AND MORPHOMETRICAL STUDY OF GESTATIONAL INDUCED CHANGES IN MOUSE LIVER USING ANTI-ADIPONECTIN RECEPTOR 2.

  2017cites this paper
• Nanomedicine: Emerging Trends in Treatment of Malaria

  2017cites this paper
• Nanomedicines against Infectious Diseases

  2016cites this paper
• Malaria sporozoite protein expression enhances baculovirus‐mediated gene transfer to hepatocytes

  2016cites this paper
• Design and therapeutic efficacy of polymer based drug delivery systems for antimalarials

  2016cites this paper
• Advanced Gold Nanomaterials for Photothermal Therapy of Cancer.

  2016cites this paper
• Current applications of nanoparticles in infectious diseases.

  2016cites this paper
• Development, differentiation, and vascular components of subcutaneous and intrahepatic Hepa129 tumors in a mouse model of hepatocellular carcinoma.

  2016cites this paper
• Combating malaria with nanotechnology-based targeted and combinatorial drug delivery strategies

  2016cites this paper
• A Glu-urea-Lys Ligand-conjugated Lipid Nanoparticle/siRNA System Inhibits Androgen Receptor Expression In Vivo

  2016cites this paper
• Targeting Mechanism of a Novel Liver-targeting Interferon IFN-CSP Involves Liver Heparan Sulfate Proteoglycan.

  2016cites this paper
• IFN-CSP Inhibiting Hepatitis B Virus in HepG2.2.15 Cells Involves JAK-STAT Signal Pathway

  2015cites this paper
• Utilizing Nanotechnology to Combat Malaria

  2015cites this paper
• UC Irvine UC Irvine Previously Published Works Title Use of labeled tomato lectin for imaging vasculature structures

  2015cites this paper
• Surface Modification and Bioconjugation of Upconversion Nanoparticles

  2015cites this paper
• Asialoglycoprotein receptor mediated hepatocyte targeting - strategies and applications.

  2015cites this paper
• High-level expression of a novel liver-targeting fusion interferon with preferred Escherichia coli codon preference and its anti-hepatitis B virus activity in vivo

  2015cites this paper
• The Importance of Ring Size and Position for the Antiplasmodial Activity of Angiotensin II Restricted Analogs

  2014cites this paper
• Lipid nanocarriers and molecular targets for malaria chemotherapy.

  2014cites this paper
• Expression of liver-targeting peptide modified recombinant human endostatin and preliminary study of its biological activities

  2014cites this paper
• Comparison of the Structure and Biological Activities of Wild-type and Mutant Liver-targeting Peptide Modified Recombinant Human Endostatin (rES-CSP) in Human Hepatocellular Carcinoma HepG2 Cells.

  2014cites this paper
• Antiplasmodial activity study of angiotensin II via Ala scan analogs

  2014cites this paper
• Nanomedicine against malaria.

  2014cites this paper
• Nano-based Drug Delivery and Diagnostic Systems

  2014cites this paper
• Advances in nanomedicines for malaria treatment.

  2013cites this paper
• RNAi in Liver Diseases

  2013cites this paper
• A study of the anti‐plasmodium activity of angiotensin II analogs

  2013cites this paper
• Nanotechnological strategies for the treatment of neglected diseases.

  2013cites this paper
• Gene Delivery Systems

  2013cites this paper
• Lipid nanoparticles encapsulating siRNAs against the androgen receptor to treat advanced prostate cancer

  2013cites this paper
• Development of nanovectors for the targeted drug delivery of antimalarials

  2013cites this paper
• Nanomedicine in Malaria

  2012cites this paper
• Methylene diphosphonate-conjugated adriamycin liposomes: preparation, characteristics, and targeted therapy for osteosarcomas in vitro and in vivo

  2012cites this paper
• Works Title Characterization of Kupffer cells in livers of developing mice Permalink

  2011cites this paper
• UNIVERSIDADE FEDERAL DO RIO GRANDE DO SUL FACULDADE DE FARMÁCIA PROGRAMA DE PÓS-GRADUAÇÃO EM CIÊNCIAS FARMACÊUTICAS DESENVOLVIMENTO E AVALIAÇÃO DA ATIVIDADE E FARMACOCINÉTICA DE NANOPARTÍCULAS LIPÍDICAS SÓLIDAS CONTENDO A ASSOCIAÇÃO DE

  2011cites this paper
• Characterization of Kupffer cells in livers of developing mice

  2011cites this paper
• Binding patterns of peptide-containing liposomes in liver and spleen of developing mice: comparison with heparan sulfate immunoreactivity

  2011influential citation
• Intracellular Bacteria and Protozoa

  2011cites this paper
• A nanovector with complete discrimination for targeted delivery to Plasmodium falciparum-infected versus non-infected red blood cells in vitro.

  2011cites this paper
• Study of the efficacy of antimalarial drugs delivered inside targeted immunoliposomal nanovectors

  2011cites this paper
• Nanotechnology applied to the treatment of malaria.

  2010cites this paper
• Targeted delivery of RNAi therapeutics with endogenous and exogenous ligand-based mechanisms.

  2010cites this paper
• Preparation, stability and in vitro evaluation of liposomes containing chloroquine

  2010cites this paper
• Anti-GD3 antibodies are targeting molecules for delivery of siRNA to melanoma

  2010cites this paper
• Liposomes and Drug Delivery

  2010cites this paper
• Properties, engineering and applications of lipid-based nanoparticle drug-delivery systems: current research and advances.

  2010cites this paper
• Targeted Delivery of RNAi Therapeutics With Endogenous and Exogenous Ligand-Based Mechanisms.

  2010cites this paper
• Cellular organization of normal mouse liver: a histological, quantitative immunocytochemical, and fine structural analysis

  2009cites this paper
• Nanoparticles in cellular drug delivery.

  2009cites this paper
• A NTI – C ANCER N ANOPODS : R ATIONAL DESIGN OF AN OLIGOARGININE BASED GENE DELIVERY VEHICLE TARGETED TO HEPATOCARCINOMA

  2009cites this paper
• Liposomal delivery of doxorubicin to hepatocytes in vivo by targeting heparan sulfate.

  2009influential citation
• State of the Art of Nanobiotechnology Applications in Neglected Diseases

  2009cites this paper
• Liposomal Polyethyleneglycol and Polyethyleneglycol-Peptide Combinations for Active Targeting to Liver In Vivo

  2008cites this paper
• Development of RNAi Therapeutics

  2008cites this paper
• Current data on ATP-containing liposomes and potential prospects to enhance cellular energy status for hepatic applications.

  2008cites this paper
• Nanoconjugate based on polymalic acid for tumor targeting.

  2008cites this paper
• Liposomes incorporating a Plasmodium amino acid sequence target heparan sulfate binding sites in liver.

  2008cites this paper
• Liposomal polyethyleneglycol and polyethyleneglycol-peptide combinations for active targeting to liver in vivo.

  2008cites this paper
• Microparticles and nanoparticles for drug delivery.

  2007cites this paper
• Parasitic diseases: Liposomes and polymeric nanoparticles versus lipid nanoparticles.

  2007cites this paper
• Small molecule modulators in epigenetics: implications in gene expression and therapeutics.

  2007cites this paper
• Interfering with disease: a progress report on siRNA-based therapeutics

  2007cites this paper
• Nanotecnologia farmacêutica aplicada ao tratamento da malária

  2007cites this paper
• Nanotecnologia farmacutica aplicada ao tratamento da malria

  2007cites this paper
• Carving Out Niches for Nanostructures: Implementation and Interplay of Building Blocks, Methods, and Tools

  2006cites this paper
• Targeting study of gelatin adsorbed clodronate in reticuloendothelial system and its potential application in immune thrombocytopenic purpura of rat model.

  2006cites this paper
• Addressing liver fibrosis with lipid-based drug carriers targeted to hepatic stellate cells

  2006cites this paper
• liver fibrosis with lipid-based drug carriers targeted to hepatic stellate cells

  year unknowncites this paper